InvestorsHub Logo

AC7880

10/27/18 8:47 AM

#269494 RE: Magnum7419 #269493

It's not too late to enter TRTC once again. TRTC now has a large footprint with rapid expansion, and with harvest imminent.

This is not some scam empty shell!! This company and stock is poised for great things in 2019.

What will 2019 look like for TRTC?

Expansion, expansion, expansion. Much of the expansion will be completed by early 2019. With expansion completion, and then new facilities in business, revenue will increase.

- TRTC financials in 2019 will increase investor confidence and move PPS substantially.

-- Staggered weekly or bi-weekly harvests (regular ongoing in 2018 Q4 and into 2019)
-- 30,000 sq ft, seeds in ground in NV ALREADY
-- ADDITIONAL 40,000 sq ft cultivation site to be built in NV
-- Cultivation in CA - some already, some additional planned
-- Reduced costs with seed to sale - no need to buy outsider wholesale
-- New dispensaries complete by Q4 in CA and in NV. Even MORE in 2019
-- Increased extraction
-- Likely CA changes in taxation, home delivery, cracking down on black-market
-- Highly possible changes at federal level in laws, banking, drug schedule. Learn what 280E is and what it will mean when it changes
-- Bi partisan support for federal law changes and drug schedule changes is increasing rapidly now, as meantime more states legalize
-- Nj ready to legalize for recreational use: TRTC well positioned in NJ already
-- TRTC just applied for 4 licenses in NJ first application period - and more to follow down the road
-- New dispensary(s) in NV to replace soon sold poorly performing location on Western Ave (sold for profit)
-- (Freemont St in Las Vegas now acknowledged by TRTC as a new location in the works.)
-- Watch for announcements of new locations opening in CA and NV
-- TRTC applying for more licenses than needed in some areas - with eye towards flipping some for profit (like they are flipping Western Ave in LV)
-- TRTC entering beverage cannabis market as well

TRTC has NEVER been better positioned. 2019 is payday for smart investors. Expansion = revenue. 2019 will show SLOWED dilution (depending on how aggressive new expansion is in 2019).

Take your risks, and then either take your rewards or take your lumps based on your decision. Just don't be like some people and blame everyone and everything but yourself for your own decisions in life.

2019 will see this investment appreciate in value.

Freeparking100

10/27/18 9:54 AM

#269496 RE: Magnum7419 #269493

Medmen paid out 30M in stock compensation their last fiscal year.

I’d love to see a comparison to other us cannabis companies of similar size. Could you share that with us? Instead of assuming we don’t want to be informed?

The whole us sector going public is really crippling your narrative when everyone can compare and contrast company practices.

kevindenver

10/27/18 11:02 AM

#269498 RE: Magnum7419 #269493

The CFO secured the financing, you call it insider enrichment, they call it doing business...

Can anyone justify why the CFO has made millions each year ?



Let's not forget NRTI.

IMO, DP and crew are toxic, thus why not even private capital will touch it. Only Dominion will do deals, and ONLY if there are "toxic" equity discounts in place.